Red Light Therapy Irradiance for Horses: The One Spec That Tells You Whether Your Device Actually Works
Share
If you are trying to evaluate whether your red light therapy device for horses actually delivers a therapeutic dose, there is exactly one specification that answers the question — and it is not wattage, not LED count, and not the price you paid. It is irradiance: the amount of light power reaching the tissue surface, measured in milliwatts per square centimetre (mW/cm²). Irradiance is the output metric. Wattage is an input metric — it tells you how much electricity the device draws from the wall, not how much therapeutic light reaches the horse. LED count tells you how many diodes are on the board, not how much usable energy they deliver per square centimetre. And yet irradiance is the specification most device marketing either buries, omits, or games — because wattage and LED count are bigger numbers that sound more impressive to buyers who have not been taught the difference.
The second point is horse-specific: equine tissue presents more barriers between the LED and the cellular target than human tissue does — and those barriers mean your horse needs more irradiance, not less. A horse has a coat (which scatters and absorbs photons), thicker skin (3–5 mm versus 1–2 mm in humans), and deeper target structures (tendons, joints, and muscle groups that sit further from the surface in a 500 kg animal than in a 70 kg human). A device designed for human facial skincare at 15 cm distance will not deliver a therapeutic dose to an equine suspensory ligament through coat, skin, and subcutaneous tissue. For a full breakdown of how wavelength interacts with tissue depth across species, our wavelength penetration guide for horses, dogs, and cats covers the physics in detail.
And the third point arms you with the math: the therapeutic dose (fluence, in J/cm²) is a simple calculation from irradiance and time — and once you know the formula, you can evaluate any device in 30 seconds. If a device's irradiance delivers 4–50 J/cm² within a 10–15 minute session, it is in the therapeutic window. If it needs 30+ minutes to reach that floor, it is underpowered for equine use. The math does not care about the brand, the price, or the LED count. It cares about irradiance multiplied by time.
The Short Answer
Irradiance (mW/cm²) is the only specification that tells you whether a device delivers a therapeutic dose to your horse's tissue.
The dose equation: irradiance (mW/cm²) × time (seconds) ÷ 1,000 = fluence (J/cm²).
The therapeutic window: approximately 4–50 J/cm² at the tissue surface for most applications.
The practical test: does the device deliver the therapeutic dose in 10–15 minutes of close contact? If yes, the irradiance is adequate for equine use. If it needs 30+ minutes, it is underpowered.
For horses specifically: equine tissue (coat + thick skin + deep targets) requires higher irradiance at the device surface than human applications. A device designed for human use may not deliver enough to the equine cellular target.
What Irradiance Actually Is — In Plain Language
Imagine pointing a garden hose at a fence. The amount of water hitting each square centimetre of the fence per second is the "irradiance" of the hose. You can increase it by turning up the pressure (more power) or by moving the hose closer (less distance). You can decrease it by moving the hose further away or by spreading the stream wider (larger area, less per point).
Irradiance in photobiomodulation is the same concept with photons instead of water. It measures how many photons hit each square centimetre of tissue per second. More photons per cm² per second = higher irradiance = faster dose delivery = shorter session time for the same therapeutic effect.
Why Irradiance Matters More Than Wattage or LED Count
| Specification | What it measures | What it does NOT tell you |
|---|---|---|
| Wattage (W) | Electricity consumed from the wall | How much of that electricity becomes therapeutic photons at the tissue surface. A large portion is lost as heat, scattered by optics, or emitted at non-therapeutic wavelengths |
| LED count | Number of diodes on the board | Output per diode. 1,000 low-power LEDs spread thinly can deliver less irradiance per cm² than 200 high-power LEDs concentrated in a smaller area |
| Total optical power (mW or W) | Total light output across all wavelengths and all directions | How that light is distributed across the treatment area, or how much reaches the tissue at the correct wavelength |
| Irradiance (mW/cm²) | Light power per unit area at the treatment surface | This IS the specification that determines the dose. It tells you exactly how much therapeutic light reaches each square centimetre of tissue per second |
The car analogy
Buying a red light therapy device based on wattage is like buying a car based on fuel tank size. A 60-litre tank does not tell you how fast the car goes, how efficient the engine is, or whether the car can tow your horse float. Wattage tells you how much electricity goes in. Irradiance tells you how much therapeutic light comes out at the treatment surface. Two 300W devices can have completely different irradiance — and the one with higher irradiance will deliver the therapeutic dose faster, regardless of whether its wattage is higher or lower.
LED count is like counting the cylinders in the engine. A 12-cylinder engine that is poorly tuned produces less power than a 6-cylinder engine that is well-engineered. The number of LEDs on the board tells you nothing about the output per LED, the beam angle, the thermal efficiency, or the power density at the tissue.
The Dose Equation: How to Calculate Whether Your Device Is Adequate
The therapeutic dose — formally called fluence — is the total energy delivered per square centimetre. The equation is simple:
Fluence (J/cm²) = Irradiance (mW/cm²) × Time (seconds) ÷ 1,000
That is the entire equation. Once you have the irradiance of your device at contact or at the treatment distance, you can calculate the fluence for any session length.
Worked examples
| Device irradiance at contact | Session time | Fluence delivered | Within therapeutic window (4–50 J/cm²)? |
|---|---|---|---|
| 10 mW/cm² | 10 min (600 sec) | 6 J/cm² | Barely — low end. Adequate for superficial tissue only. 15 min raises it to 9 J/cm² |
| 10 mW/cm² | 30 min (1,800 sec) | 18 J/cm² | Yes — but 30 minutes per area is impractical for equine use |
| 30 mW/cm² | 10 min (600 sec) | 18 J/cm² | Yes — solidly within the window |
| 50 mW/cm² | 10 min (600 sec) | 30 J/cm² | Yes — mid-range therapeutic dose |
| 50 mW/cm² | 15 min (900 sec) | 45 J/cm² | Yes — near the upper end of the window |
| 100 mW/cm² | 10 min (600 sec) | 60 J/cm² | At or above the upper threshold. May enter diminishing returns territory (biphasic response) |
| 100 mW/cm² | 5 min (300 sec) | 30 J/cm² | Yes — therapeutic dose in a shorter session |
The biphasic dose-response: more is not always better
Photobiomodulation follows the Arndt-Schulz principle — a biphasic dose-response curve. Below approximately 2–4 J/cm², the cellular response is minimal. Between 4 and 50 J/cm², the response is therapeutic. Above approximately 50–60 J/cm², the response plateaus or becomes inhibitory.
This means that doubling the irradiance and keeping the same session time does not double the benefit — it may push the dose above the therapeutic window into diminishing returns or inhibition. Higher irradiance is useful because it lets you deliver the same therapeutic dose in a shorter time — not because more energy is always better. A 50 mW/cm² device delivering 30 J/cm² in 10 minutes is therapeutically equivalent to a 100 mW/cm² device delivering 30 J/cm² in 5 minutes. Same dose. Same cellular response. Different time.
Why Horses Need More Irradiance Than Humans
The irradiance at the device surface is not the irradiance at the cellular target. Between the LED and the cytochrome c oxidase in the mitochondria, the photons must pass through multiple barriers — and horses have more of these barriers than humans.
| Barrier | Human | Horse | Effect on irradiance reaching the target |
|---|---|---|---|
| Coat / hair | Minimal — most treatment areas are bare skin or thin hair | Variable — thin summer coat to thick winter coat. Dark coats absorb more at the surface | Coat scatters and absorbs photons before they reach the skin. Clean, short, light-coloured coat = minimal loss. Thick, dark, matted coat = significant loss |
| Skin thickness | 1–2 mm in most treatment areas | 3–5 mm in most body areas | Thicker skin absorbs and scatters more photons in transit. 2–3× more skin to penetrate means measurably less photon delivery at the same depth |
| Subcutaneous tissue | Variable — typically thin over joints, moderate over muscle | Variable — but proportionally deeper over muscle groups and joints in a larger animal | More tissue between the surface and the target means more attenuation before the photons reach the mitochondria |
| Target tissue depth | Joints, tendons, and muscles are closer to the surface in a smaller body | Deep muscle groups (longissimus, gluteals), large joints (hock, stifle), and tendons under thick tissue require photons to travel further | The deeper the target, the fewer photons arrive. Deep equine targets receive substantially fewer photons than shallow human targets at the same surface irradiance |
The practical implication
A device that delivers 20 mW/cm² at skin contact may be adequate for a human knee (thin skin, shallow joint). The same 20 mW/cm² may be inadequate for an equine hock — because the photons must pass through coat, 3–5 mm of skin, and subcutaneous tissue before reaching the joint capsule. The irradiance that arrives at the cellular target is a fraction of what started at the surface, and that fraction is smaller in a horse than in a human because of the additional barriers. This is why a device "rated for" human use is not automatically adequate for equine use — the same surface irradiance delivers less to the equine target.
Contact vs Distance: Why Form Factor Affects the Irradiance Equation
Irradiance decreases with distance — roughly following the inverse square law. Doubling the distance reduces irradiance to approximately one quarter. This makes the form factor of the device critically important for equine applications.
| Device form factor | Treatment distance | Irradiance advantage | Equine suitability |
|---|---|---|---|
| Wearable (blanket, boot, wrap, pad) | Zero — LEDs sit directly against the coat | Maximum. No distance loss. All emitted photons enter the coat at point-blank range | Best for equine. Eliminates the distance variable entirely. The irradiance at the device surface IS the irradiance at the coat |
| Handheld (held against the body) | Near-zero — held in light contact | Excellent. Minimal distance loss when held in snug contact | Excellent for targeted areas. The handler controls the contact pressure and positioning. For the full cross-species versatility of handhelds, our multi-species device guide covers the detail |
| Panel (wall-mounted, 15–30 cm distance) | 15–30 cm from the tissue | Significantly reduced. Irradiance at 15 cm is a fraction of contact irradiance. At 30 cm, roughly one quarter | Impractical for horses. A horse will not stand at a fixed distance from a wall panel. Even if it did, the distance loss means much higher surface output is needed to deliver an adequate dose |
Why contact devices are the equine standard
The reason equine PBM devices are designed as wearables and handhelds — not as wall-mounted panels — is not just about the horse's willingness to stand still. It is about irradiance efficiency. A contact device that delivers 50 mW/cm² at the LED surface delivers 50 mW/cm² at the coat surface. A panel that delivers 100 mW/cm² at the LED surface may deliver only 25 mW/cm² at 30 cm — and that is before the coat, skin, and subcutaneous tissue attenuate it further.
Contact eliminates the single biggest source of irradiance loss. For equine applications where every photon counts, this is not a convenience feature — it is a physics requirement.
How to Evaluate Any Equine Device's Irradiance in 60 Seconds
- Step 1: Find the irradiance specification. Look for mW/cm² at a stated distance (at contact, at 5 cm, at 15 cm). If the device does not publish irradiance — only wattage or LED count — you cannot evaluate its dose delivery, and that omission tells you something.
- Step 2: Note the measurement distance. "100 mW/cm² at contact" is a very different number from "100 mW/cm² at 30 cm." Contact is realistic for equine wearables. 30 cm is the measurement distance for human panels and is not relevant to how equine contact devices are used.
- Step 3: Plug into the dose equation. Irradiance (mW/cm²) × your planned session time (seconds) ÷ 1,000 = fluence (J/cm²). If the result is between 4 and 50 J/cm² for a 10–15 minute session, the device is adequate.
- Step 4: Check for third-party verification. Was the irradiance measured by the manufacturer or independently? Independent testing is more reliable — some manufacturers publish inflated numbers based on single-LED peak output rather than average across the treatment area.
The peak vs average trick: some manufacturers publish the irradiance of the brightest single LED at zero distance — the absolute peak output of one diode pressed against a sensor. The average irradiance across the full treatment area at contact is always lower than this peak number. Ask for the average across the treatment area, not the peak of one LED. The average is what your horse's tissue experiences across the entire treatment surface.
Irradiance Requirements by Equine Application
| Application | Target tissue depth | Minimum practical irradiance at contact | Why |
|---|---|---|---|
| Skin wound healing | Superficial — skin surface and dermis | 20–30 mW/cm² | Target is at or near the surface. Less attenuation through tissue. Lower irradiance is adequate because the photons do not need to travel far |
| Back / muscle soreness | Moderate — 1–3 cm below the surface | 30–50 mW/cm² | Muscle sits beneath skin and subcutaneous fat. More photons need to start the journey for an adequate number to arrive at depth |
| Joint comfort (hock, stifle, fetlock) | Moderate to deep — joint capsule beneath skin, ligament, and tendon layers | 40–60 mW/cm² | The joint capsule is not on the surface — photons must pass through multiple tissue layers. Higher starting irradiance compensates for attenuation |
| Tendon / ligament injury | Variable — superficial (SDFT) to deep (DDFT at pastern level) | 30–60 mW/cm² | Superficial tendons like the SDFT are accessible; deep structures like the DDFT in the hoof require maximum practical irradiance. Our DDFT injury guide covers the depth problem in detail |
| General wellness / senior maintenance | Mixed — back, hindquarters, joints | 30–50 mW/cm² | Broad coverage at moderate irradiance covers the range of tissue depths involved in general comfort support |
These numbers are practical guidelines, not prescriptions. The optimal dose for a specific condition, tissue type, and individual horse is an area of active research. Published equine PBM studies use a wide range of parameters, and standardised equine-specific dosing protocols have not yet been established with the precision of human PBM guidelines. Use these figures as a framework for evaluating device adequacy — and work with your vet or a PBM practitioner for condition-specific protocols.
What Happens When the Irradiance Is Too Low
A device with inadequate irradiance for equine use does not harm the horse — it simply fails to deliver a therapeutic dose in a practical session time. The result is wasted time and wasted money, not damage.
- Sessions become impractically long. A device delivering 10 mW/cm² needs 30 minutes to reach 18 J/cm² — possible, but tedious. Most horse owners will not sustain a 30-minute handheld session daily.
- The dose may not reach deep targets. Even with a long session, if the surface irradiance is too low, the photons that penetrate through coat, skin, and subcutaneous tissue to reach a deep target like a hock joint or a deep muscle group may fall below the cellular activation threshold — regardless of session length.
- The owner concludes "it doesn't work." An underpowered device used for 10 minutes delivers a sub-therapeutic dose. The owner sees no results, concludes PBM is ineffective, and abandons the therapy. The therapy did not fail — the dose was never delivered.
The $50 panel problem
The most common irradiance failure in equine PBM is an owner buying a cheap consumer panel designed for human facial skincare and trying to use it on a horse. These panels are engineered for thin human skin at 10–15 cm distance with a session time of 10–20 minutes — and they work well for that purpose. But hold one against a horse's back through a coat, and the irradiance that reaches the equine muscle tissue is a fraction of what the skin surface receives, which is already a fraction of what the device delivers at its designed treatment distance. The device is not broken. It was never designed for the job. An equine-specific device at twice the price that delivers an adequate dose is a better investment than a human device at half the price that delivers none.
Coat Colour and Condition: The Variable Most Owners Miss
The horse's coat is the first barrier between the LED and the tissue — and it is not a constant. It changes with season, grooming, and colour.
| Coat variable | Effect on photon delivery | What to do |
|---|---|---|
| Dark coat (black, dark bay) | Absorbs more photons at the surface — melanin in dark hair absorbs red and NIR light, reducing transmission to the skin | Ensure snug contact. Consider slightly longer sessions (12–15 min instead of 10). Parting the hair may improve direct skin contact in targeted areas |
| Light coat (grey, palomino, white) | Reflects more but absorbs less — higher proportion of photons reach the skin surface | Standard session parameters. Light coats are the "easiest" for photon delivery |
| Thick winter coat | Significant attenuation — more hair layers scatter and absorb photons before they reach the skin | Groom thoroughly before treatment. Body-clip the treatment area if PBM is a regular part of the winter routine, or time intensive treatment for after the spring shed |
| Short summer coat | Minimal impact — thin coat is nearly transparent to red and NIR light | Standard parameters. Summer is the easiest season for equine PBM |
| Matted or dirty coat | Dirt, mud, and matted hair absorb and scatter photons significantly more than clean, brushed coat | Always brush before treatment. A clean coat is not just hygiene — it is a dose-delivery issue. Groom first, treat second |
The grooming-as-dose-optimisation principle
Grooming the treatment area before a PBM session is not optional courtesy — it is a dose delivery practice. A quick brush removes loose hair, dander, and debris that would otherwise absorb photons before they reach the skin. For owners using PBM as part of a daily routine, grooming the treatment area should be the first step — before the device goes on. It takes two minutes and measurably improves photon delivery.
Conclusion: One Number, One Equation, One Answer
Irradiance — measured in mW/cm² at the treatment surface — is the specification that determines whether your device delivers a therapeutic dose to your horse's tissue. Not wattage. Not LED count. Not price. Not marketing claims about "clinical strength" or "professional grade." Irradiance multiplied by time gives you fluence (J/cm²), and fluence within the 4–50 J/cm² therapeutic window in a 10–15 minute session is the entire physics of whether the therapy works.
Horses need more irradiance at the device surface than humans because equine coat, thicker skin (3–5 mm), and deeper target structures attenuate photons before they reach the mitochondria. A device designed for human skin at 15 cm distance is not automatically adequate for equine use. Purpose-built equine devices deliver adequate irradiance at contact — which is the most efficient way to maximise photon delivery in a species with multiple attenuation barriers.
The practical test is simple: does the device's published irradiance, multiplied by your session time, produce a fluence within the therapeutic window? If yes, the device is adequate. If no — because the irradiance is too low or is not published at all — either the device is underpowered for equine use, or you have no way to evaluate it. In both cases, the answer is the same: you need a device with known, adequate irradiance and the confidence of a manufacturer who publishes the number.
Brush the horse. Check the contact. Run the session. And trust the one number that actually matters.
Frequently Asked Questions
What irradiance does a red light therapy device need for horses?
An equine red light therapy device needs enough irradiance at the tissue surface to deliver a therapeutic fluence (dose) of approximately 4 to 50 joules per square centimetre (J/cm²) within a practical session length of 10 to 15 minutes. Working backward from the dose equation — irradiance (mW/cm²) multiplied by time (seconds) divided by 1,000 equals fluence (J/cm²) — a device delivering 30 to 60 mW/cm² at contact produces 18 to 54 J/cm² in a 10-minute session, which falls within the established therapeutic window. Below 20 mW/cm², sessions need 25 minutes or more to reach the lower therapeutic threshold, which is impractical for most equine use. The critical factor for horses specifically is that equine skin is thicker than human skin (3 to 5 mm versus 1 to 2 mm), and the coat adds an additional attenuation layer, so the irradiance at the skin surface needs to be higher than for human applications to ensure adequate photon delivery to the target tissue beneath.
What is irradiance in red light therapy?
Irradiance is the amount of light power delivered per unit area at the treatment surface, measured in milliwatts per square centimetre (mW/cm²). It tells you how much therapeutic light actually reaches the tissue — not how much electricity the device draws (that is wattage), not how many LEDs are on the board (that is count), and not how bright the device looks to your eye (that is perception). Irradiance is an output metric: it describes what the device delivers to the tissue, which is the number that determines the therapeutic dose. Two devices can have identical wattage but vastly different irradiance depending on LED efficiency, beam angle, optical design, and thermal losses.
Why do horses need more irradiance than humans?
Horses have three physical barriers between the LED and the target tissue that humans typically do not, each of which attenuates (reduces) the photon delivery. First, the coat: horse hair scatters and absorbs some photons before they reach the skin surface. A clean, short summer coat has minimal impact, but a thick winter coat or a dark-coloured coat attenuates more. Second, skin thickness: equine skin is approximately 3 to 5 mm thick in most body areas, compared to 1 to 2 mm for human skin. Third, tissue depth: many equine target structures — tendons, joint capsules, deep muscle groups — sit further from the surface than their human equivalents, simply because the horse is a larger animal. The combined effect means that a higher irradiance at the device surface is needed to ensure that an adequate number of photons reach the cellular target at depth.
How do you calculate the dose from irradiance?
The dose — formally called fluence — is calculated as irradiance (mW/cm²) multiplied by time (seconds), divided by 1,000, which gives you joules per square centimetre (J/cm²). For example, a device delivering 50 mW/cm² at contact, applied for 600 seconds (10 minutes), delivers a fluence of 30 J/cm². The established therapeutic window for most photobiomodulation applications is approximately 4 to 50 J/cm² at the tissue surface. Below approximately 2 J/cm², cellular response is minimal. Above approximately 50 to 60 J/cm², the biphasic dose-response curve means additional energy produces diminishing returns or even inhibitory effects.
Why is wattage misleading for comparing red light therapy devices?
Wattage measures how much electricity the device draws from the power supply — it is an input metric, not an output metric. What matters for photobiomodulation is how much of that electricity is converted into therapeutic photons that reach the tissue at the right wavelengths and adequate intensity. A significant portion of the electrical energy in any LED device is lost as heat, absorbed by the housing, scattered by the optics, or emitted at wavelengths outside the therapeutic range. Two devices drawing 300 watts can deliver dramatically different irradiance at the treatment surface. Comparing devices by wattage is like comparing cars by fuel consumption — it tells you the cost to run, not the performance you get.
